What is the recommended dosing of fexofenadine (Allegra) for treating sinus pressure and congestion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fexofenadine Dosing for Sinus Pressure and Congestion

For sinus pressure and congestion, the recommended dose of fexofenadine (Allegra) is 60 mg twice daily or 180 mg once daily with water for adults and children 12 years and older. 1

Dosing Guidelines by Age

  • Adults and Children 12 Years and Older:

    • 60 mg twice daily OR
    • 180 mg once daily with water
  • Children 6-11 Years:

    • 30 mg twice daily with water
  • Patients with Decreased Renal Function:

    • Adults and children ≥12 years: Start with 60 mg once daily
    • Children 6-11 years: Start with 30 mg once daily

Efficacy for Sinus Symptoms

Fexofenadine is a second-generation antihistamine that effectively treats several allergic rhinitis symptoms, including:

  • Sneezing
  • Rhinorrhea (runny nose)
  • Itchy nose, palate, or throat
  • Itchy, watery, red eyes

While fexofenadine can provide some relief for nasal congestion, it's important to note that:

  1. It has limited efficacy for nasal congestion compared to other symptoms 2
  2. Studies have shown fexofenadine can reduce nasal congestion in perennial allergic rhinitis, with effects beginning within the first week of treatment 3
  3. For significant nasal congestion, combination therapy with a decongestant may be more effective 4

Therapeutic Considerations

First-Line vs. Second-Line Therapy

Intranasal corticosteroids are generally recommended as first-line therapy for allergic rhinitis with significant symptoms affecting quality of life, particularly when nasal congestion is a predominant symptom 5. However, fexofenadine may be appropriate as first-line therapy in certain situations:

  • For mild intermittent symptoms
  • When patients prefer oral medication over nasal sprays
  • When rapid onset of action is desired (onset of relief ≤2 hours) 4

Benefits of Fexofenadine

  • Non-sedating at recommended doses 2
  • Does not impair driving or psychomotor performance 6
  • Once-daily dosing option (180 mg) for convenience
  • Rapid onset of action (within 2 hours) 4
  • Long duration of action (24-hour relief) 7
  • Safety profile similar to placebo 6

Limitations for Sinus Congestion

While fexofenadine can help with some aspects of sinus pressure and congestion, it has limitations:

  • Less effective for nasal congestion than for other allergic rhinitis symptoms
  • May not adequately address significant nasal congestion as a single agent

Alternative and Combination Approaches

For patients with predominant nasal congestion:

  1. Intranasal corticosteroids are more effective than oral antihistamines for nasal congestion 5

  2. Combination therapy options:

    • Fexofenadine + pseudoephedrine (oral decongestant) can provide complementary activity for nasal congestion 4
    • However, oral decongestants should be used with caution in patients with hypertension, cardiac arrhythmia, glaucoma, or hyperthyroidism 2
  3. Intranasal antihistamines (e.g., azelastine, olopatadine) may be more effective than oral antihistamines for nasal congestion 2

Important Precautions

  • Oral decongestants (if used in combination) can cause insomnia, irritability, and palpitations 2
  • Monitor patients with hypertension when using oral decongestants 2
  • Fexofenadine does not cause significant sedation at recommended doses, unlike some other antihistamines 2, 6

Duration of Treatment

Fexofenadine can be used for the duration of symptoms. Evaluate treatment response after 4-6 weeks, and consider adjusting the medication regimen if symptoms persist 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Allergic Rhinitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The systemic safety of fexofenadine HCl.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.